MedPath

Effectiveness of supplementation with Omega-3/6 fatty acid in 3-6 years old children with attention-deficit/hyperactivity symptoms

Not Applicable
Recruiting
Conditions
F90.0
F90.1
Disturbance of activity and attention
Hyperkinetic conduct disorder
Registration Number
DRKS00003197
Lead Sponsor
Klinik und Poliklinik für Psychiatrie und Psychotherapie des Kindes-und Jugendalters der Universität zu Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
250
Inclusion Criteria

Healthy children aged between 3-6 with visiting a kindergarden/prescholol, parents speak fluently German, at least 90. Percentile in screening of the parents and teacher

Exclusion Criteria

Intolerance to study agent or any food with fish oil or supplementation with polyunsaturated fatty acids
Other treatments to reduce behavioural problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in der ADHD-symptomatology: FBB-ADHD-V-total-score parents (baseline, after 4 and 8 months); changes in der ADHD-symptomatology: FBB-ADHS-V-total-score teacher (baseline, after 4 and 8 months)
Secondary Outcome Measures
NameTimeMethod
changes in emotional state: CBCL 1 ½-5 (Child behavior checklist) (baseline, after 4 and 8 months)<br>changes in sequential processing scales: K-ABC (Kaufman Assessment Battery for Children) (baseline, after 4 months);<br>changes in simultaneous processing scales: K-ABC (baseline, after 4 months):<br>changes in achievement scales: K-ABC (baseline, after 4 months);<br>changes in polyunsaturated fatty acids (Omega-3/6): blood sample (baseline, after 4 months)<br>
© Copyright 2025. All Rights Reserved by MedPath